| 000 | 00000cam u22002054a 4500 | |
| 001 | 000046029795 | |
| 005 | 20200722161019 | |
| 006 | m d | |
| 007 | cr cnu|||unuuu | |
| 008 | 180403s2018 gw a o 000 0 eng d | |
| 020 | ▼a 9783662558805 (electronic bk.) | |
| 020 | ▼a 3662558807 (electronic bk.) | |
| 020 | ▼z 9783662558782 (print) | |
| 020 | ▼z 3662558785 | |
| 035 | ▼a 1789125 ▼b (N$T) | |
| 035 | ▼a (OCoLC)1030302735 ▼z (OCoLC)1030485853 ▼z (OCoLC)1030593734 ▼z (OCoLC)1030757848 ▼z (OCoLC)1033638055 ▼z (OCoLC)1066676263 ▼z (OCoLC)1079828711 | |
| 040 | ▼a GW5XE ▼b eng ▼e rda ▼e pn ▼c GW5XE ▼d YDX ▼d N$T ▼d EBLCP ▼d OCLCF ▼d MERER ▼d COO ▼d UAB ▼d JG0 ▼d OCLCQ ▼d U3W ▼d OCLCA ▼d OCLCQ ▼d SNK ▼d USU ▼d OCLCO ▼d UPM ▼d VT2 ▼d CNCEN ▼d GRG ▼d OCLCO ▼d WYU ▼d OCLCQ ▼d OCLCA ▼d LVT ▼d OCLCA ▼d DKU ▼d OCLCO ▼d OCLCQ ▼d CAUOI ▼d OCLCO ▼d AUD ▼d OCLCO ▼d ESU ▼d OCLCO ▼d UKAHL ▼d OCLCQ ▼d OCLCO ▼d 211092 | |
| 082 | 0 4 | ▼a 615.7/883 ▼2 23 |
| 084 | ▼a 615.7883 ▼2 DDCK | |
| 090 | ▼a 615.7883 | |
| 245 | 0 0 | ▼a Behavioral neurobiology of psychedelic drugs ▼h [electronic resource] / ▼c Adam L. Halberstadt, Franz X. Vollenweider, David E. Nichols, editors. |
| 260 | ▼a Berlin, Germany : ▼b Springer, ▼c 2018. | |
| 300 | ▼a 1 online resource (x, 430 p.) : ▼b ill.(some col.). | |
| 490 | 1 | ▼a Current topics in behavioral neurosciences, ▼x 1866-3370 ; ▼v volume 36 |
| 650 | 0 | ▼a Hallucinogenic drugs. |
| 650 | 0 | ▼a Neurobiology. |
| 650 | 0 | ▼a Clinical neuropsychology. |
| 650 | 7 | ▼a MEDICAL ▼x Pharmacology. ▼2 bisacsh. |
| 650 | 7 | ▼a Clinical neuropsychology. ▼2 fast ▼0 (OCoLC)fst00864390. |
| 650 | 7 | ▼a Hallucinogenic drugs. ▼2 fast ▼0 (OCoLC)fst00950651. |
| 650 | 7 | ▼a Neurobiology. ▼2 fast ▼0 (OCoLC)fst01036315. |
| 650 | 1 4 | ▼a Biomedicine. |
| 650 | 2 4 | ▼a Neurosciences. |
| 650 | 2 4 | ▼a Psychopharmacology. |
| 650 | 2 4 | ▼a Medicinal Chemistry. |
| 650 | 1 2 | ▼a Hallucinogens. |
| 650 | 2 2 | ▼a Brain ▼x drug effects. |
| 650 | 2 2 | ▼a Delusions ▼x chemically induced. |
| 650 | 2 2 | ▼a Neurobehavioral Manifestations ▼x drug effects. |
| 655 | 4 | ▼a Electronic books |
| 700 | 1 | ▼a Halberstadt, Adam L. |
| 700 | 1 | ▼a Vollenweider, Franz X. |
| 700 | 1 | ▼a Nichols, David E. |
| 776 | 0 8 | ▼i Print version: ▼z 3662558785 ▼z 9783662558782 ▼w (DLC) 2018931899 ▼w (OCoLC)1002015742 |
| 830 | 0 | ▼a Current topics in behavioral neurosciences ; ▼v 36. ▼x 1866-3370. |
| 856 | 4 0 | ▼3 EBSCOhost ▼u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=1789125 |
| 991 | ▼a E-Book(소장) |
소장정보
| No. | 소장처 | 청구기호 | 등록번호 | 도서상태 | 반납예정일 | 예약 | 서비스 |
|---|---|---|---|---|---|---|---|
| No. 1 | 소장처 의학도서관/e-Book 컬렉션/ | 청구기호 CR 615.7883 | 등록번호 E34000034 | 도서상태 대출불가(열람가능) | 반납예정일 | 예약 | 서비스 |
컨텐츠정보
목차
This volume brings together the latest basic and clinical research examining the effects and underlying mechanisms of psychedelic drugs. Examples of drugs within this group include LSD, psilocybin, and mescaline. Despite their structural differences, these compounds produce remarkably similar experiences in humans and share a common mechanism of action. Commonalities among the substances in this family are addressed both at the clinical and phenomenological level and at the basic neurobiological mechanism level. To the extent possible, contributions relate the clinical and preclinical findings to one another across species. The volume addresses both the risks associated with the use of these drugs and the potential medical benefits that might be associated with these and related compounds.